These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 31074368)

  • 1. Exploring Secondary Metabolites Database of Apocynaceae, Menispermaceae, and Annonaceae to Select Potential Anti-HCV Compounds.
    Barros RPC; Scotti L; Scotti MT
    Curr Top Med Chem; 2019; 19(11):900-913. PubMed ID: 31074368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Silico Studies Designed to Select Sesquiterpene Lactones with Potential Antichagasic Activity from an In-House Asteraceae Database.
    Acevedo CH; Scotti L; Scotti MT
    ChemMedChem; 2018 Mar; 13(6):634-645. PubMed ID: 29323468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
    Lim SK; Othman R; Yusof R; Heh CH
    Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of antileishmanial sesquiterpene lactones from SistematX database using a combined ligand-/structure-based virtual screening approach.
    Herrera-Acevedo C; Dos Santos Maia M; Cavalcanti ÉBVS; Coy-Barrera E; Scotti L; Scotti MT
    Mol Divers; 2021 Nov; 25(4):2411-2427. PubMed ID: 32909084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
    Patil VM; Gupta SP; Samanta S; Masand N
    Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential inhibitors for HCV NS3 genotype 4a by combining protein-ligand interaction fingerprint, 3D pharmacophore, docking, and dynamic simulation.
    El-Hasab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2018 May; 36(7):1713-1727. PubMed ID: 28531373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Brancale A
    Bioorg Med Chem Lett; 2017 Feb; 27(4):936-940. PubMed ID: 28089348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applications of computer-aided approaches in the development of hepatitis C antiviral agents.
    Ganesan A; Barakat K
    Expert Opin Drug Discov; 2017 Apr; 12(4):407-425. PubMed ID: 28164720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational Chemistry Study of Natural Alkaloids and Homemade Databank to Predict Inhibitory Potential Against Key Enzymes in Neurodegenerative Diseases.
    Lorenzo VP; Alves MF; Scotti L; Dos Santos SG; de Fatima Formiga Melo Diniz M; Scotti MT
    Curr Top Med Chem; 2017; 17(26):2926-2934. PubMed ID: 28828994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular design, synthesis and biological evaluation of cage compound-based inhibitors of hepatitis C virus p7 ion channels.
    Shiryaev VA; Radchenko EV; Palyulin VA; Zefirov NS; Bormotov NI; Serova OA; Shishkina LN; Baimuratov MR; Bormasheva KM; Gruzd YA; Ivleva EA; Leonova MV; Lukashenko AV; Osipov DV; Osyanin VA; Reznikov AN; Shadrikova VA; Sibiryakova AE; Tkachenko IM; Klimochkin YN
    Eur J Med Chem; 2018 Oct; 158():214-235. PubMed ID: 30218908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Speeding up Early Drug Discovery in Antiviral Research: A Fragment-Based in Silico Approach for the Design of Virtual Anti-Hepatitis C Leads.
    Speck-Planche A; Dias Soeiro Cordeiro MN
    ACS Comb Sci; 2017 Aug; 19(8):501-512. PubMed ID: 28437091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-Assisted Discovery of Alkaloids with Schistosomicidal Activity.
    Menezes RPB; Viana JO; Muratov E; Scotti L; Scotti MT
    Curr Issues Mol Biol; 2022 Jan; 44(1):383-408. PubMed ID: 35723407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural compounds isolated from Brazilian plants are potent inhibitors of hepatitis C virus replication in vitro.
    Jardim AC; Igloi Z; Shimizu JF; Santos VA; Felippe LG; Mazzeu BF; Amako Y; Furlan M; Harris M; Rahal P
    Antiviral Res; 2015 Mar; 115():39-47. PubMed ID: 25557602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening.
    Singh A; Jana NK
    Comput Biol Chem; 2017 Dec; 71():144-151. PubMed ID: 29096380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering molecular properties and docking studies of hepatitis C and non-hepatitis C antiviral inhibitors - A computational approach.
    Venkatesan A; Febin Prabhu Dass J
    Life Sci; 2017 Apr; 174():8-14. PubMed ID: 28259653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure- and Ligand-Based Approaches to Evaluate Aporphynic Alkaloids from Annonaceae as Multi-Target Agent Against Leishmania donovani.
    Lorenzo VP; Lúcio AS; Scotti L; Tavares JF; Filho JM; Lima TK; Rocha JD; Scotti MT
    Curr Pharm Des; 2016; 22(34):5196-5203. PubMed ID: 27174814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Modelling in Studies for Hepatitis C Virus (HCV) NS3 Protease.
    Mukhametov A
    Curr Top Med Chem; 2016; 16(12):1351-61. PubMed ID: 26585936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrocyclic Hepatitis C Virus NS3/4A Protease Inhibitors: An Overview of Medicinal Chemistry.
    Pillaiyar T; Namasivayam V; Manickam M
    Curr Med Chem; 2016; 23(29):3404-3447. PubMed ID: 27160539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.